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Abstract. Background/Aim: A subset of carcinomas metastatic
to the ovary can exhibit growth patterns closely resembling
ovarian mucinous cystadenoma and borderline tumor. They can
be misinterpreted as underlying primary ovarian mucinous
tumors and can be erroneously used to suggest that the
carcinomatous component arises from mucinous precursor
lesions. Materials and Methods: We investigated the
clinicopathological characteristics of 11 cases of metastatic
carcinoma that had metastasized from colorectal and
pancreatobiliary carcinoma and mimicked primary ovarian
mucinous tumors. Results: The patient age ranged from 37 to 81
years old. Seven patients presented to gynecologists with non-
specific pelvic symptoms similar to those of primary ovarian
tumors. The primary tumor was identified before the detection
of the ovarian lesion in 6 cases, synchronously in 5, and
postoperatively in 1 case. The ovarian tumors were bilateral in
6 cases. The greatest dimension of the metastatic tumors ranged
from 4.8 to 23.0 cm. Multinodularity was present in 7 cases, and
surface involvement was identified in 5 cases. An infiltrative
growth pattern was present, at least focally, in 8 cases. Six and
2 cases exhibited cystadenomatous and borderline-like growth
patterns, respectively. Conclusion: Although the diagnosis of
metastatic tumors to the ovary is possible in most cases on the
basis of clinical presentation and standard diagnostic criteria,
their differential diagnosis may be problematic because of
morphological patterns that strikingly overlap with those of
primary ovarian benign, borderline, and malignant mucinous
tumors. The possibility of metastases should be considered when
evaluating ovarian mucinous tumors.
The ovary is a common site of metastasis from a variety of
primary tumors (1, 2). Although in most cases the primary
tumors are diagnosed before the detection of the metastatic
ovarian tumors, an ovarian mass can sometimes be the initial
clinical manifestation of the primary disease. It is well
established that primary epithelial tumors of the ovary can
be mimicked by metastatic carcinoma from the
abdominopelvic organs, leading to misdiagnosis (3). It is of
utmost importance to correctly classify ovarian tumors as
either primary or metastatic because the prognoses of these
conditions differ significantly and determining the correct
diagnosis has implications on the effective clinical
management of patients (2, 4, 5).
Among primary ovarian epithelial tumors, mucinous
tumors pose the greatest difficulty with regard to distinction
of primary from metastatic tumors (6). Metastatic
carcinomas to the ovary are usually easily distinguished from
primary ovarian mucinous tumors, including mucinous
borderline tumors and carcinomas, when they exhibit
characteristic gross and histological features. Primary
ovarian mucinous tumors are typically large, unilateral, and
multilocular cystic lesions, with smooth capsules. Moreover,
primary ovarian mucinous carcinoma most often arises in
association with mucinous cystadenoma and borderline
tumors. Although primary mucinous ovarian carcinomas can
exhibit destructive stromal invasion, they frequently show a
dominantly expansile (confluent glandular) invasive pattern
(7). In contrast, the typical features of metastatic carcinomas
that distinguish them from primary ovarian mucinous tumors
include a smaller size, bilaterality, involvement of the
ovarian surface and superficial cortex, a multinodular growth
pattern, and a dominantly infiltrative pattern of stromal
invasion (4, 6, 8, 9).
A subset of metastatic carcinomas can manifest with one
or more features suggesting a primary ovarian tumor both
clinically and pathologically. These include i) presentation
as a large, unilateral, multilocular cystic tumor lacking
surface involvement, sometimes as the first manifestation of
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a disease with a clinically occult extraovarian source, and ii)
certain growth patterns, including cystadenomatous,
borderline-like, and expansile, which cannot be readily
recognized as primary or metastatic. The metastases
exhibiting borderline-like growth patterns often show
obvious nuclear atypia and thus simulate ovarian mucinous
borderline tumors with intraepithelial carcinoma. Metastases
with small infiltrative foci simulate microinvasion derived
from the adjacent mucinous borderline tumor. Furthermore,
metastases with sufficiently crowded confluent glands, but
lacking destructive stromal invasion simulate primary
ovarian mucinous carcinomas with an expansile invasive
pattern (6, 8, 10-12). Despite recognition of the ability of
these metastases to simulate primary tumors, and recent
studies providing refined diagnostic criteria for primary
ovarian mucinous tumors (4, 13, 14), the problem of
distinguishing these tumors remains unresolved. This issue
is compounded by the fact that in routine practice, metastatic
mucinous carcinomas are more common than primary
ovarian mucinous carcinomas, with those of gastrointestinal
and pancreaticobiliary origin being the most commonly
encountered types (15, 16).
Herein, we comprehensively describe the clinicopathological
characteristics of colorectal and pancreaticobiliary carcinomas
that metastasized to the ovaries and mimicked primary ovarian
tumors, with emphasis on the ability of these tumors to exhibit
gross and histological features simulating primary ovarian
tumors.
Materials and Methods
Case selection. Following approval (4-2018-0193) by the
Institutional Review Board at the Severance Hospital, 11 cases of
metastatic carcinoma to the ovary of colorectal (7 cases), pancreatic
(3 cases), or extrahepatic biliary (1 case) origin were extracted from
the surgical pathology files between July 2015 and December 2017.
The diagnosis of an ovarian metastasis was based on standard
diagnostic criteria (4, 9, 13, 17). The clinical features and
intraoperative findings were obtained by review of the patients’
electronic medical records or by communication with the referring
gynecologists. Available preoperative and postoperative imaging
materials were reviewed. In all cases, the primary tumor was
available for histological examination. Pathology reports and gross
photographs were also reviewed.
Pathological examination. The resected tissues were initially examined
by pathologists before fixation in 10% neutral-buffered formalin. After
fixation for 12-24 h, the tissues were examined macroscopically and
sectioned. After processing with an automatic tissue processor (Peloris
II, Leica Microsystems, Wetzlar, Germany), the sections were
embedded in paraffin blocks. Four-micrometer-thick slices were cut
from each formalin-fixed, paraffin-embedded tissue block and stained
with hematoxylin and eosin using an automatic staining instrument
(Ventana Symphony System, Ventana Medical Systems, Tucson, AZ,
USA). After staining, the slides were covered with a glass coverslip
and sent to 2 board-certified pathologists specialized in gynecological
oncology for examination. They examined all available hematoxylin
and eosin-stained slides using light microscopy (BX43 System
Microscope, Olympus, Tokyo, Japan), made definite pathological
diagnoses, and chose the most representative slide to perform
immunohistochemical staining. For descriptive purposes, architectural
growth patterns of the tumors were assessed as cystadenomatous,
borderline-like, expansile, or infiltrative, on the basis of their
resemblance to these patterns seen in primary ovarian mucinous
tumors (6, 8, 18). Nuclear atypia was assessed as mild, moderate, or
severe. Additional pathological findings that were assessed included
the presence of surface involvement, multinodular growth,
extracellular mucin, and signet-ring cells.
Immunohistochemistry. The paraffin-embedded slices were
deparaffinized and rehydrated with a xylene and alcohol solution.
Immunohistochemical staining was performed using an automatic
immunostaining instrument (Ventana Benchmark XT, Ventana
Medical Systems) according to the manufacturer’s recommendations
(19-36). Antigen retrieval was performed using a Cell Conditioning
Solution (CC1, Ventana Medical Systems). The slices were
incubated with primary antibodies against cytokeratin 7 (CK7;
1:100; clone OV-TL 12/30; Dako, Glostrup, Denmark), CK20
(1:100; clone Ks20.8; Dako), and caudal-related homeobox 2
(CDX2; 1:400; clone EPR2764Y; Cell Marque, Rocklin, CA, USA).
After chromogenic visualization using an ultraView Universal DAB
Detection Kit (Ventana Medical Systems), slices were
counterstained with hematoxylin. Appropriate positive and negative
controls were concurrently stained to validate the staining method.
Negative controls were prepared by substituting non-immune serum
for the primary antibody and resulted in no detectable staining. For
CK7 and CK20 immunostaining, staining with a moderate-to-strong
intensity in the cell membrane was interpreted as positive
expression. For CDX2 immunostaining, staining with a moderate-
to-strong intensity in the nuclei was interpreted as positive
expression. Positive staining was considered diffuse when at least
50% of tumor cells were immunoreactive and focal when less than
50% of the cells were stained.
Results
Clinical features. The patients’ ages ranged from 37 to 81
years (median, 51 years). There was no history of malignancy
before the detection of colorectal, pancreatobiliary, or ovarian
tumors in any patient. Seven patients presented to
gynecologists with nonspecific pelvic symptoms, including
palpable pelvic masses, and abdominal pain, discomfort,
and/or distension. The primary tumors and ovarian metastases
were simultaneously detected using preoperative imaging
studies (computed tomography or magnetic resonance
imaging) and/or exploratory laparotomy in 4 cases. In 7
cases, the tumors presented asynchronously, with the primary
tumor diagnosis preceding the ovarian tumor diagnosis in 6
cases. The exact time interval between the diagnosis of the
primary tumor and that of the ovarian tumor was known for
4 asynchronous cases. For the 4 cases with the primary tumor
diagnosis established first, the mean time interval to diagnosis
of the ovarian tumor was 19 months (range=4-56 months). In
the remaining synchronously presented case, the primary
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tumor was diagnosed by follow-up investigations after
ovarian resection. In this case, the clinical presentation was
an ovarian mass, which was thought to be ovarian cancer
upon clinical assessment. Pancreatic carcinoma was
diagnosed 6 months after the ovarian tumor was removed.
Extra-abdominal metastases sites included the lung in 2 cases
and the vertebrae in 1 case.
Radiologically, the initial impressions of the ovarian
tumors were primary ovarian cystic tumor in 6 cases, and 2
cases were diagnosed as primary ovarian cystic tumor versus
metastasis. The remaining 3 cases were diagnosed as ovarian
metastasis. The greatest dimension of tumors ranged from
4.8 to 23.0 cm (median, 11.4 cm).
All patients except 1 underwent unilateral (3 patients) or
bilateral (8 patients) salpingo-oophorectomy. Six of the 8
patients who underwent bilateral salpingo-oophorectomy
underwent hysterectomy concurrently. Peritoneal carcinomatosis
was observed in 5 patients and ascites in 7 patients.
Intraoperative frozen sections of the ovarian masses were
requested in 4 cases. An intraoperative diagnosis of metastatic
adenocarcinoma was made in 2 cases, and 2 cases were
diagnosed as at least mucinous borderline tumors. The initial
histopathological diagnoses of the ovarian tumors were primary
mucinous carcinoma in 2 cases and mucinous borderline tumor
in 1 case. In the other cases, metastatic tumors were either
diagnosed (7 cases) or favored (1 case).
Eight patients received postoperative chemotherapy. Two
experienced progression of the disease and were lost to follow-
up after 6 months. All the remaining patients experienced
disease progression and died of their disease (8 patients); 1 of
these patients was lost to follow-up after a short time.
Pathological features. Bilateral ovarian involvement was
present in 6 cases. The appearance of the external surface was
recorded for 9 tumors and was noted to be smooth in 2 tumors,
irregular in 2 tumors, studded with tumor nodules in 3 tumors,
and ruptured in 4 tumors, with adhesions or fibrinous exudate
in 5 tumors and focal hemorrhage in 3 tumors. The sectioned
surfaces were predominantly solid in 2 tumors, solid and cystic
in 5 tumors, and multilocular cystic in 4 tumors. The cystic
contents were recorded as mucoid in 6 tumors, serosanguinous
in 3 tumors, and serous in 2 tumors. Grossly identifiable areas
of necrosis were recorded in 8 tumors.
All the tumors, to varying degrees, had foci that were
indistinguishable from, or closely simulated, primary ovarian
mucinous tumors when viewed in isolation. However, all of
them also had 1 or more morphological features
characteristic of metastatic tumors. Multinodular growth was
seen in 7 tumors, all of which demonstrated foci of
uninvolved ovarian tissue between the tumor nodules. The
nodules were often present in the superficial cortex. Ovarian
surface implants were observed in 5 of 9 cases for which
sections of the external surface were available. In 2 cases
surface involvement could not be definitively determined
because of the lack of a specific gross description of this
aspect, and a lack of evidence of a definitive ovarian surface
on available slides. The surface implants typically consisted
of irregularly infiltrating glands within a desmoplastic,
sometimes hyalinized, stroma.
Histologically, dilated and occasionally markedly cystic
glands set in a variable amount of stroma represented the
dominant morphological pattern in many tumors (Figure 1A).
Infiltrating foci consisting of angulated tubular glands,
irregular-shaped tumor cell nests, or singly scattered tumor
cells were observed in 8 tumors (Figure 1B). The infiltrative
growth pattern was accompanied by cystadenomatous and/or
borderline-like patterns in 8 tumors (Figure 1C). In areas of
cystadenomatous pattern, a single layer of mucinous epithelium
exhibited minimal or no nuclear atypia. Nuclear stratification
was not identified. A cystadenomatous growth pattern was the
only pattern observed in 1 case. In contrast, tumors exhibiting
extensive borderline-like growth patterns were characterized
by multiple cystic lesions and glands of various sizes,
intraluminal infoldings and papillary epithelial projections, and
nuclear stratification, without definitive stromal invasion
(Figure 1D). Tumors with marked atypia simulated mucinous
borderline tumors with intraepithelial carcinoma (Figure 1E).
Moreover, tumors with small infiltrative foci adjacent to the
borderline-like areas simulated microinvasive mucinous
carcinoma. The borderline-like pattern was exclusive in 2
tumors. Complex papillary structures with little intervening
stroma, which are indicative of an expansile invasive pattern,
were prominent in 2 tumors (Figure 1F). An admixture of the
aforementioned morphological features was common and
resulted in a particularly varied appearance, even between
individual slides from the same patient.
The lining epithelium of the glands and cysts demonstrated
variable mucin production. Mucin-producing epithelial cells
were observed at least focally in all tumors. They were
usually tall and columnar with abundant intracytoplasmic
mucin (Figure 2A). Signet-ring cells comprised greater than
10% of the tumor cell population in 4 tumors, warranting a
diagnosis of Krukenberg tumor. In other cases, sporadic
signet-ring cells were identified. Three tumors contained
colloid carcinoma-like areas with epithelium floating within
mucin (Figure 2B). Areas resembling an ovarian mucinous
borderline tumor, with or without intraepithelial carcinoma,
were observed in all tumors. Bland-appearing, single-layered
mucinous epithelium was seen in 4 tumors. Areas showing a
non-mucinous epithelium were present in 3 tumors. They
exhibited 3 main appearances: i) nonspecific cuboidal or
columnar epithelium lining glands and cysts with a variable
degree of nuclear atypia; ii) gland-forming adenocarcinoma
with a cribriform architecture or focal cord-like infiltration
mimicking high-grade endometrioid adenocarcinoma (Figure
2C); and iii) undifferentiated carcinoma.
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The nature of the stroma and its prominence varied
greatly, both within individual tumors and among the
ovarian tumors as a group. Fibromatous stroma was present
in 5 tumors, desmoplastic stroma in 3 tumors (Figure 2D),
and hypocellular to hyalinized stroma in 3 tumors (Figure
2E). Luteinized stromal cells were seen in 7 tumors.
Although the stromal component was typically
overshadowed by the glandular proliferation, in occasional
cases the presence of superficially located benign glands
and cysts within expanded fibrous stroma led to a
remarkable mimicry of primary ovarian adenofibroma or
cystadenofibroma. In tumors with a less prominent stromal
component, the relatively benign-appearing cysts mimicked
a mucinous cystadenoma with low power magnification.
Intraluminal necrotic debris was observed in 9 tumors, and
7 tumors demonstrated a garland-like pattern of cribriform
epithelium around the area of necrosis (Figure 2F). Broad
zones of tumor cell necrosis were seen in 4 tumors. Ovarian
lymphatic invasion was unequivocally identified in only 3
tumors, although striking involvement of the paratubal
lymphatics was noted in some other cases. Intracytoplasmic
hyaline globules were present in rare cases.
Immunophenotypical features. The epithelial cells in all cases
examined showed variable staining intensity according to the
primary origin. All cases of metastatic colorectal carcinoma
showed strong and diffuse immunoreactivities for CK20 (Figure
3A) and CDX2 (Figure 3B). None of them exhibited CK7
expression (Figure 3C). In all cases of metastatic
pancreatobiliary carcinoma CK7 expression was strong and
diffuse (Figure 3D). CK20 immunoreactivity was weak and
patchy (Figure 3E), and CDX2 immunoreactivity was absent in
all cases of metastatic pancreatobiliary carcinoma (Figure 3F).
Discussion
Metastatic tumors involving the ovary account for 5-30% of
ovarian malignancies (37). They continue to be the source of
numerous problems in differential diagnosis for the
pathologists and have been a subject of much interest in the
last few decades (38-40). Although overall information on
ovarian metastasis from gastrointestinal and pancreatobiliary
carcinomas is limited, the phenomenon is probably more
frequent than the number of reported cases would indicate.
Even with preoperative imaging studies, the primary lesions
were not always diagnosed before surgery (41). The
operative findings frequently showed abnormalities in and
around the primary site that raised suspicion of disease of
non-ovarian origin; however, in some cases, the primary
tumor was not recognized or had previously been removed.
In 1 case in this study, the primary tumor was not detected
until 6 months postoperatively despite repeated preoperative
and postoperative abnormal computed tomographic scans.
The relatively occult nature of pancreatobiliary carcinoma
has previously been described (42).
The median diameter of metastatic tumors was 11.4 cm, and
bilateral ovarian involvement was observed in 6 (54.5%) cases.
Multinodularity was observed in 63.5%, and cystic change was
identified in 81.8% of the cases. Histologically, all cases showed
1 or more morphological features indicative of metastatic
carcinoma. However, a ‘maturation’ phenomenon, i.e. the
progression from a cystadenomatous pattern through a
borderline-like pattern to a carcinomatous component, and
variable degrees of nuclear atypia were both observed in several
cases (6). When cystadenomatous and/or borderline-like growth
patterns are admixed with a carcinomatous component, these
patterns may be considered underlying mucinous precursor
lesions, leading to the misdiagnosis of metastatic carcinoma as
primary ovarian mucinous carcinoma (1, 43).
It is difficult to classify an ovarian mucinous tumor as a
primary or metastatic lesion based solely on histological
features. Thus, several studies have been performed to find
meaningful clinical and radiological features for classifying
ovarian mucinous tumors (4, 16). According to a previous
study applying the algorithm based on tumor size and
laterality, all cases of ovarian metastasis that originated from
the pancreaticobiliary tract were classified correctly as
metastatic lesions (16). In contrast, this algorithm was not
useful in diagnosing metastatic colorectal carcinoma. Instead,
microscopic surface implants and an infiltrative growth
pattern were found to be useful clues for diagnosing
metastatic colorectal carcinoma (4).
In addition to a cystadenomatous or borderline-like growth
pattern, a transition from bland-looking or mildly atypical
nuclei to moderately-to-severely atypical nuclei was
identified in several cases. Although this maturation
phenomenon is one of the characteristic morphological
features of primary ovarian mucinous carcinoma, previous
studies have reported that approximately one-third of
metastatic mucinous carcinomas exhibit the maturation
phenomenon (4). Furthermore, if well-differentiated glands
and cysts are scattered in fibrous stroma, the lesion may
mimic ovarian mucinous adenofibroma or mucinous
cystadenoma, depending on the amount of fibrous stroma
(38). During the intraoperative frozen section examination,
the maturation phenomenon can lead to the misdiagnosis of
a metastatic lesion as primary ovarian mucinous tumor
because of the limited amount of specimen. Thus, a
combination of medical history, clinical information, and
histopathology is crucial to avoid misdiagnoses (38).
Some previous studies have assessed the diagnostic value
of immunohistochemical staining for distinguishing primary
ovarian mucinous tumor from metastatic mucinous
carcinoma. The application of immunostaining for CK7 and
CK20 does not appear to be useful (44, 45). Instead of using
the CK7/CK20 immunoprofile, recent studies have reported
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that overexpression of CK17 and reduction of deleted in
pancreatic carcinoma 4 (DPC4) expression can be used as
potential biomarkers for determining whether a lesion is of
pancreaticobiliary origin (46, 47).
In conclusion, we investigated the clinicopathological
features of 11 ovarian metastases from carcinomas of
colorectal and pancreatobiliary origin. Although ovarian
metastases can be diagnosed according to clinical features
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Figure 1. Histological features: growth pattern. A: Cystically dilated glands and intervening fibrous stroma. B: Variable-sized, irregular-shaped
glands and individually scattered tumor cells. C: Areas of cystadenomatous and borderline-like patterns. D: Areas resembling ovarian mucinous
borderline tumor. E: Areas resembling ovarian mucinous borderline tumor with intraepithelial carcinoma. F: Areas resembling ovarian mucinous
carcinoma of expansile invasive pattern. Original magnification: A, ×40; B, ×100; C, ×100; D, ×100; E, ×200; F, ×40.
and standard diagnostic criteria, their differential diagnosis
can be challenging because of morphological patterns that
overlap with those of primary ovarian mucinous tumors.
Therefore, the possibility of metastatic lesions should be
considered when evaluating ovarian mucinous tumors. In
addition, further studies are necessary for developing an
immunohistochemical panel to discriminate primary and
metastatic mucinous tumors.
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Figure 2. Histological features: lining epithelium and stroma. A: Tall columnar epithelium containing abundant intracytoplasmic mucin. B: Areas
resembling colloid carcinoma. C: Areas resembling endometrioid carcinoma. D: Desmoplastic stromal reaction observed adjacent to infiltrating
tumor glands. E: Hypocellular, edematous stroma. F: Large, cribriform glands with punctate central necrosis, resembling comedonecrosis of ductal
carcinoma in situ of the breast. Original magnification: A, ×200; B, ×100; C, ×100; D, ×200; E, ×40; F, ×100.
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Figure 3. Immunohistochemical staining results. A and B: Strong and diffuse (A) cytokeratin 20 (CK20; membranous) and (B) caudal-related
homeobox 2 (CDX2; nuclear) immunoreactivities in metastatic colorectal carcinoma. C: Lack of CK7 expression in metastatic colorectal carcinoma.
D: Strong and diffuse membranous CK7 immunoreactivity in metastatic pancreatic carcinoma. E: Weak and patchy membranous CK20 expression
in metastatic pancreatic carcinoma. F: Lack of CDX2 expression in in metastatic extrahepatic cholangiocarcinoma. Original magnification: A,
×40; B, ×40; C, ×100; D, ×200; E, ×200; F, ×200.
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